Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2017 Q1- Text added to 2017 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Abstract, ADAPTIR, AMG, AnalgesiX, Aptevo, arrive, ASPIRE, Aziyo, bacteria, BiTE, buydown, CanGaroo, compound, construct, CStone, daratumumab, death, depression, Dr, ECM, Envelope, extracellular, forecasted, fracture, hip, immaterial, Interventional, istiratumab, Lancet, matrix, NASH, Oberland, pancreatic, pericardial, postpartum, prejudice, protein, ratified, Reddy, repair, SAB, showcased, slightly, Summit, susceptible, tied, tiered, understatement, understating, untreated, variation, voluntarily, women, xCella, YTD
Valuein 2017 Q1 filing- Value in 2017 Q2 filing
Original filings
Filing view